Amyloid cascade hypothesis of Alzheimer's disease and α7 nicotinic receptor

Japanese Journal of Psychopharmacology

Volumn 22, Issue 2, 2002, Pages 49-53

  Hashimoto, Kenji ^a   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

7 Nicotinic receptor; Amyloid protein; Alzheimer's disease; Endogenous ligand; Nicotine

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; AMYLOID; AMYLOID BETA PROTEIN; ARR 17779; N (4 ACETYL 1 PIPERAZINYL) 4 FLUOROBENZAMIDE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; HUMAN; NEUROPROTECTION; NEUROTOXICITY; PATHOLOGY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; LIGANDS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION;

EID: 0036247181     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease
2. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor -mediated glutamate cytotoxicity
3. β-amyloid peptides as direct cholinergic neuromodulators: A missing link?
4. The α7 nicotinic acetylcholine receptor in neuronal plasticity
5. β-amyloid: Friend or foe
6. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors
7. Genes, models and Alzheimer's disease
8. Nerve inflammation halts trial for Alzheimer's drug
9. Nicotinic receptor abnormalities in Alzheimer's disease
10. β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease
11. Smoking and Parkinson's and Alzheimer's disease: Review of the epidemiological studies
12. Effects of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task
13. Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells
14. Expression of nicotinic receptor subunit mRNAs in lymphocytes from normal and patients with Alzheimer's disease
15. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
16. Effect of FK960, a putative cognitive enhancer, on synaptic transmission in CA1 neurons of rat hippocampus
17. Correlative memory deficits. Aβ elevation, and amyloid plaques in transgenic mice
18. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
19. Nicotinic receptors in the brain: Correlating physiology with function
20. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α-7 neuronal nicotinic receptors and neuronal CNS receptors
21. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: Studies with DMXB (GTS-21)
22. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity
23. α7 Nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyloid-induced neurotoxicity
24. Aβ immunization: Moving Aβ peptide from brain to blood
25. AR-R17779, an α7 nicotinic agonist, improves learning and memory in rats
26. 1-42 peptide with α7 nicotinic receptors
27. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
28. β-amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
29. Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons
30. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
31. (-)-Spiro[1-azabicyclo[2.2.2] octane-3, 5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor
32. Beta amyloid inhibits presynaptic nicotinic receptors in nerve terminals from rat hippocampus
33. Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications
34. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice
35. Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse
36. Nicotinic receptor-mediated protection against β-amyloid neurotoxicity
37. Nicotinic α-7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage
38. Development of ligands for in vivo imaging of cerebral nicotinic receptors
39. AN-1792 (Elan)
40. Imaging brain cholinergic activity with positron emission tomography: Its role in the evaluation of cholinergic treatments in Alzheimer's dementia
41. 1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors
42. 1-42binds to α7 nicotinic acetylcholine receptor with high affinity
43. Nicotinic acetylcholine receptors in Alzheimer's disease
44. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: Histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein
45. Presynaptic nicotinic acetylcholine receptors